Iron oxide-enhanced MR lymphography: initial experience.
The detection of nodal metastases is of utmost importance in oncologic imaging. Ultrasmall superparamagnetic iron oxide particles (USPIO) are novel contrast agents specifically developed for MR lymphography. After intravenous administration, they are taken up by the macrophages of the lymph nodes, where they accumulate. They reduce the signal intensity (SI) of normally functioning nodes on postcontrast T2-and T2*-weighted images through the magnetic susceptibility effects on iron oxide. Metastatic nodes, in which macrophages are replaced by tumor cells, show no significant change in SI on postcontrast T2-and T2*-weighted images. Early clinical experience suggests that USPIO-enhanced MR lymphography improves the sensitivity and specificity for the detection of nodal metastases. It also suggests that micrometastases could be detected in normal-sized nodes. This article reviews the physiochemical properties of USPIO contrast agents, their enhancement patterns, and early clinical experience.
Bellin
M F
MF
Department of Radiology, Hôpital Pitié-Salpêtière, 83 Boulevard de l'Hôpital, 75651 Cedex 13, Paris, France. marie-france.bellin@psl.ap-hop-paris.fr
Beigelman
C
C
Precetti-Morel
S
S
D003287:Contrast Media; D006801:Humans; D007275:Injections, Intravenous; D058085:Iron Compounds / Q000008:administration & dosage / Q000009:adverse effects; D008207:Lymphatic Metastasis / Q000175:diagnosis*; D008220:Lymphography / Q000379:methods*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009367:Neoplasm Staging
D003287:Contrast Media; D058085:Iron Compounds